Altogether suggest that certain drugs that could alter the expression of NEAT1 in SN might potentially function as prevention or therapy of PD for a specific subpopulations of PD patients (Simchovitz et al., 2019). The gene discussed is NEAT1; the disease is Parkinson disease.